Revelation Biosciences Inc is a clinical-stage life science company focused on rebalancing inflammation to optimize health using its proprietary formulation, Gemini. The company is developing a pipeline of potential products based on Gemini, which is its proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD), a synthetic version of monophosphoryl lipid A (MPLA). PHAD is a small fragment of lipopolysaccharide (LPS) that stimulates TLR4 and leads to controlled production of multiple cytokines and chemokines that modulate the innate and adaptive immune response. The company operates through one reportable segment focused on the prevention and treatment of disease by developing and commercializing therapeutics that modulate the innate immune system.
Last trade$3.77
Day change-$0.05 (-1.31%)
Day range$3.73 – $4.19
Volume12,402
Market cap$2M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$2.17M
Price / earnings
—
Price / book
0.3×
Price / sales
—
EV / sales
—
EV / EBITDA
0.55×
Profitability
Earnings per share
-$31.35
Return on assets
-178.01%
Return on equity
-246.63%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0×
Current ratio
3.98×
Quick ratio
3.98×
Cash ratio
3.92×
Cash flow
Price / cash flow
—
Price / free cash flow
—
Free cash flow
-$10.21M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for REVB, quarterly periods
Line item
Q3 FY2026 Sep 30, 2026
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Revenue
$0
$0
$0
$0
$0
$0
$0
$0
Cost of revenue
$0
$0
$0
$0
$0
$0
$0
$0
Gross profit
$0
$0
$0
$0
$0
$0
$0
$0
Selling, general and administrative
$1.87M
$1.74M
$1.72M
$1.61M
$1.02M
$1.14M
$1.24M
$1.15M
Research and development
$1.51M
$1.92M
$1.38M
$964.19K
$922.86K
$1.32M
$858.83K
$605.5K
Total operating expenses
$3.38M
$3.66M
$3.09M
$2.57M
$1.94M
$2.46M
$2.09M
$1.75M
Operating income
-$3.38M
-$3.66M
-$3.09M
-$2.57M
-$1.94M
-$2.46M
-$2.09M
-$1.75M
Interest expense
$0
$0
$0
$0
$0
$0
$0
$0
Income before taxes
-$3.32M
-$3.32M
-$3.01M
-$2.51M
-$1.91M
-$2.44M
-$2.05M
-$1.73M
Income taxes
$0
$0
$0
$0
$0
$0
$0
$0
Net income
-$3.32M
-$3.32M
-$3.01M
-$2.51M
-$1.91M
-$2.44M
-$2.05M
-$1.73M
Net income attributable to common shareholders
-$3.32M
-$3.32M
-$8.69M
-$2.51M
-$4.68M
-$5.63M
-$2.05M
-$1.73M
EBITDA
-$3.38M
-$3.65M
-$3.09M
-$2.57M
-$1.94M
-$2.45M
-$2.09M
-$1.75M
Basic earnings per share
-$5.92
-$6.09
-$18.97
-$11.41
-$49.51
-$196.28
-$177.38
-$416.25
Diluted earnings per share
-$5.92
-$6.09
-$18.97
-$11.41
-$49.51
-$196.28
-$177.38
-$416.25
Recent news
Company coverage with links to the original publishers.
U.S. stock futures declined slightly on Friday after two consecutive days of gains, following President Trump's withdrawal of EU tariffs and better-than-expected Q3 GDP figures at 4.4%. Key movers include Intel down 12% on weak guidance, Capital One down 3.31% on earnings miss, Revelation Biosciences up 38% on FDA approval pathway, and CSX up 2.99% despite missing estimates. Bank of America's fund manager survey shows institutional investors at their most bullish since 2021.
Do elections impact the price of penny stocks or not?
The post How an Election Impacts Penny Stocks appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.
Here’s the latest list of major oversold players in this sector, having an RSI near or below 30.
BIOLASE, Inc. (NASDAQ: BIOL)
On Jan. 29, Biolase reported full-year 2023 interim revenue of $48.9 million to $49.2 million, up 1% year-over-year compared to the consensus of $49.21 million. The company’s stock fell around 43% over the past five days ...
Shares of Skechers U.S.A., Inc. (NYSE: SKX) shares fell during Friday’s session after the company reported mixed fourth-quarter financial results.
Skechers said fourth-quarter revenue increased 4.4% year-over-year to $1.96 billion, which missed the consensus estimate of $2.03 billion, according to Benzinga Pro. The company reported quarterly earnings of 56 cents per share, which beat analyst estimates of 54 cents per share.
Skechers shares fell 6.9% to $59.21 on Friday.
Here are some other stocks moving in today's mid-day session.
Gainers
Intelligent Bio Solutions Inc. (NASDAQ: INBS) shares jumped 77.6% to $4.28. Intelligent Bio Solutions said it sees preliminary second-quarter revenue of $0.76 million.
Minim, Inc. (NASDAQ: MINM) shares rose 34.4% to $6.76 after gaining more than 22% on Thursday.
Remark Holdings, Inc. (NASDAQ: MARK) shares climbed 33% to $0.6802.
Kopin Corporation (NASDAQ: KOPN) jumped 30% to $2.4050.
BioRestorative Therapies, Inc. (NASDAQ: BRTX) rose 26.3% to $2.73.
Mountain Crest Acquisition Corp. IV (NASDAQ: MCAF) gained 23% to $14.65.
Tyra Biosciences, Inc. (NASDAQ: TYRA) gained 21.8% to $15.84. Tyra Biosciences announced a $200 million private placement financing.
Meta Platforms, Inc. (NASDAQ: META) rose 18.9% to $469.34 as the company reported upbeat fourth-quarter financial results and initiated a quarterly dividend of 50 cents per share.
CCSC Technology International Holdings Limited (NASDAQ: CCTG) gained 18.2% to $4.6099 after dipping around 82% on Thursday.
Roma Green Finance Limited (NASDAQ: ROMA) gained 15.8% to $0.8697 after gaining around 5% on Thursday.
Deckers Outdoor Corporation (NYSE: DECK) surged 14% to $879.03 after reporting better-than-expected third-quarter financial results.
Trugolf, Inc. (NASDAQ: TRUG) shares jumped 14% to ...
Shares of Meta Platforms, Inc. (NASDAQ: META) rose sharply in today’s pre-market trading as the company reported upbeat fourth-quarter financial results and initiated a quarterly dividend of 50 cents per share.
The company also announced a $50 billion increase to its share repurchase authorization.
Meta shares climbed 16.5% to $460.02 in pre-market trading
Here are some other stocks moving in pre-market trading.
Gainers
CCSC Technology International Holdings Limited (NASDAQ: CCTG) gained 55.1% to $6.05 in pre-market trading after dipping around 82% on Thursday.
Trugolf, Inc. (NASDAQ: TRUG) shares jumped 33.1% to $1.77 in pre-market trading after dipping 55% on Thursday.
Roma Green Finance Limited (NASDAQ: ROMA) gained 25.2% to $0.94 in pre-market trading after gaining around 5% on Thursday.
Jiuzi Holdings, Inc. (NASDAQ: JZXN) shares gained 20% to $0.84 in pre-market trading.
C3is Inc. (NASDAQ: CISS) shares rose 18.8% to $0.1625 in pre-market trading. S.H.N. Financial recently reported a 9.1% stake in the company.
Minim, Inc. (NASDAQ: MINM) shares rose 18.7% to $5.97 in pre-market trading after gaining more than 22% on ...
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.